Form 4: Procter & Gamble COO Shailesh Jejurikar Reports Stock Option Grant and Beneficial Ownership Changes
SEC Form 4 Filing
Chief Operating Officer of Procter & Gamble, Shailesh Jejurikar, reports acquisition of stock options and changes in beneficial ownership of common stock.
Summary
- On October 1, 2024, Shailesh Jejurikar, Chief Operating Officer of Procter & Gamble, reported transactions involving the company's stock.
- Jejurikar acquired 94,338 stock options with an exercise price of $173.04, exercisable from October 1, 2027, and expiring on September 29, 2034.
- The report also details changes in beneficial ownership of common stock, including direct ownership of 9,855.9125 shares and indirect ownership through a retirement plan trustee (2,902.3575 shares), the Sankhya S Jejurikar Revocable Trust (19,757 shares), and the Shailesh Jejurikar Trust (17,849 shares).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing of stock option grants and changes in beneficial ownership, which is a common practice.
Positives
- The acquisition of stock options by a key executive can be seen as a positive sign, aligning their interests with the company's long-term performance.
Future Outlook
The document does not contain specific forward-looking statements, but the stock option grant suggests an expectation of future value creation.
Industry Context
Executive stock option grants are a common practice in publicly traded companies like Procter & Gamble to incentivize performance and align management interests with shareholders.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in large, publicly traded companies such as Procter & Gamble.
- Companies like Unilever, Nestle, and Johnson & Johnson also utilize stock options as part of their executive compensation plans.
- The size and terms of the grant are generally benchmarked against peer companies and industry standards to ensure competitiveness and alignment with performance goals.
Stakeholder Impact
- The stock option grant could potentially incentivize the COO to improve company performance, benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of earliest transaction (stock option grant). |
| 10/01/2027 | Date the stock options become exercisable. |
| 09/29/2034 | Expiration date of the stock options. |
| 10/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.